Laura Prolo

Laura Prolo, MD, PhD, directs the Prolo lab, which uses newly developed genetic and epigenetic tools to understand what molecular pathways drive tumor invasion, and how these pathways can be targeted for treatment. 

After receiving her A.B. in Biology and Philosophy-Neuroscience-Psychology from Washington University in St. Louis, she completed her MD and PhD in Neuroscience from Stanford University. She remained at Stanford for Neurosurgery residency, then completed a fellowship in Pediatric Neurosurgery at University of Washington/Seattle Children’s Hospital. Dr. Prolo’s research program focuses on advancing and applying evolving molecular technologies for the diagnosis, characterization and treatment of children with brain tumors.

Clinical Research, Neuro-oncology, Neurosurgery